Chuck Ence is COO & CAO at RELMADA THERAPEUTICS, INC. (RLMD). They have made 3 open-market trades across 1 company since 2024, most recently 2025-11-05.
CIK 0001697779
3 open-market purchases totalling $712K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RLMD | 403,931 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2025-11-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.